“…Cucurbitacins have been gaining attention of scientists for their potential anti-cancer effects for decades (Lee et al, 2010; Alghasham, 2013; Cai et al, 2015), which process a broad range of pharmacological activities, including anti-inflammatory, antipyretic, and anti-cancer activities (Kaushik et al, 2015). In particular, the anti-cancer activities of cucurbitacins through antiproliferation (Mao et al, 2019; Saeed et al, 2019), inhibition of migration and invasion (Touihri-Barakati et al, 2017; Zou et al, 2018), induction of cell apoptosis (Ding et al, 2017; He et al, 2017; Liu et al, 2018; Mao et al, 2019), autophagy (Ni et al, 2018; Lin et al, 2019), and cell cycle arrest promotion are of great interest (Liu et al, 2018). For instance, cucurbitacins B, D, E, and I are the most wildly studied variants and exhibit general in vitro and in vivo anti-cancer effects.…”